Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD8

CD8

Brief Information

Name:Cluster of differentiation 8
Target Synonym:CD8 Antigens
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:15
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
Cat. No. Species Product Description Structure Purity Feature
FABm003-05 Mouse APC-CY7-Labeled Monoclonal Anti-Human CD8 Antibody, Mouse IgG
ACRO Quality

Part of Bioactivity data

FABm003-05-Cell-based assay
 CD8 FACS

Flow cytometric analysis of Human peripheral blood lymphocytes respectively staining with APC-CY7-Labeled Monoclonal Anti-Human CD8 Antibody Mouse IgG1 (Cat. No. FABm003-05) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 2.5e5 cells in a final volume of 100 µL), compared with isotype control antibody. APC-CY7 signal was used to evaluate the binding activity (QC tested).

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
89Zr-Df-crefmirlimab IAB-22-M2C Phase 3 Clinical Imaginab Inc Solid tumours; Skin Melanoma; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Multiple Sclerosis; Lymphoma; Leukoencephalopathy, Progressive Multifocal; Carcinoma, Non-Small-Cell Lung; Melanoma Details
RB-0003 RB-0003; BNT-111 Phase 2 Clinical Biontech Se, Tron Melanoma Details
CD8+ memory T cell therapy (Stanford University) Phase 2 Clinical Stanford University Leukemia; Leukemia, Myelogenous, Chronic; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute Details
GEN-009 GEN-009 Phase 2 Clinical Genocea Biosciences Inc Skin Melanoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung Details
VE-800 VE-800 Phase 2 Clinical Vedanta Biosciences Inc Esophageal Neoplasms; Stomach Neoplasms; Colorectal Neoplasms; Melanoma; Neoplasm Metastasis Details
EBViNT Cell (Eutilex) Phase 2 Clinical Eutilex Lymphoma, Extranodal NK-T-Cell Details
ZED88082A ZED88082A Phase 2 Clinical Umcg The University Medical Center Groningen Neoplasms; Neoplasm Metastasis Details
NY-ESO-1-specific autologous CD8+ T-cell therapy (Fred Hutchinson Cancer Research Center) Phase 1 Clinical Fred Hutchinson Cancer Research Center, National Cancer Institute Liposarcoma; Sarcoma, Synovial; Sarcoma Details
MTX-101 (Mozart Therapeutics) MTX-101 (Mozart Therapeutics) Phase 1 Clinical Mozart Therapeutics Inc Diabetes Mellitus, Type 1; Autoimmune Diseases; Celiac Disease Details
Fluorine-18 (18F) CD8-targeted imaging radiopharmaceutical(Ge Healthcare) GEH200521 (18F); GEH-200521 Phase 1 Clinical Ge Healthcare Solid tumours; Neoplasms Details
Tcrx T cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine) Phase 1 Clinical Second Affiliated Hospital School Of Zhejiang University School Of Medicine Stomach Neoplasms; Esophageal Neoplasms Details
SCRI-E2CAR_EGFRtv1 SCRI-E2CAR_EGFRtv1 Phase 1 Clinical Umoja BioPharma Inc Osteosarcoma Details
AGX-148 AGX-148; AGX148 Phase 1 Clinical AgonOx Inc Squamous Cell Carcinoma of Head and Neck; Neoplasms; Colorectal Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Lung Neoplasms; Melanoma Details
SNA-006 68Ga-NODAGA-SNA006; SNA-006; 68-Ga-NODAGA-SNA-006 Phase 1 Clinical Smartnuclide Biopharma Solid tumours Details
AGX-392 AGX-392 AgonOx Inc Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message